These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 30831571)

  • 1. Differentiation of Cognitive Deficit Profiles in Multiple Sclerosis Patients: Latent Profile Analysis.
    Slavković S; Lazić M; Honan C; Nađ Č; Brkić-Jovanović N; Golubović Š
    Med Princ Pract; 2019; 28(4):373-379. PubMed ID: 30831571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pattern of neuropsychological impairment in the early phase of relapsing-remitting multiple sclerosis.
    Olivares T; Nieto A; Sánchez MP; Wollmann T; Hernández MA; Barroso J
    Mult Scler; 2005 Apr; 11(2):191-7. PubMed ID: 15794394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying and understanding cognitive profiles in multiple sclerosis: a role for visuospatial memory functioning.
    van Dam M; Krijnen EA; Nauta IM; Fuchs TA; de Jong BA; Klein M; van der Hiele K; Schoonheim MM; Hulst HE
    J Neurol; 2024 May; 271(5):2195-2206. PubMed ID: 38409536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A one-year follow-up study of the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT) in relapsing-remitting multiple sclerosis: an appraisal of comparative longitudinal sensitivity.
    López-Góngora M; Querol L; Escartín A
    BMC Neurol; 2015 Mar; 15():40. PubMed ID: 25886168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Audio Recorded Cognitive Screen (ARCS) in patients with multiple sclerosis: a practical tool for multiple sclerosis clinics.
    Lechner-Scott J; Kerr T; Spencer B; Agland S; Lydon A; Schofield PW
    Mult Scler; 2010 Sep; 16(9):1126-33. PubMed ID: 20621944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A brief neuropsychological screening test battery for cognitive dysfunction in Brazilian multiple sclerosis patients.
    Negreiros MA; Mattos P; Landeira-Fernandez J; Paes RA; Alvarenga RP
    Brain Inj; 2008 May; 22(5):419-26. PubMed ID: 18415722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive impairment differs between primary progressive and relapsing-remitting MS.
    Ruet A; Deloire M; Charré-Morin J; Hamel D; Brochet B
    Neurology; 2013 Apr; 80(16):1501-8. PubMed ID: 23516324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis.
    Zivadinov R; Sepcic J; Nasuelli D; De Masi R; Bragadin LM; Tommasi MA; Zambito-Marsala S; Moretti R; Bratina A; Ukmar M; Pozzi-Mucelli RS; Grop A; Cazzato G; Zorzon M
    J Neurol Neurosurg Psychiatry; 2001 Jun; 70(6):773-80. PubMed ID: 11385012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive impairment has a strong relation to nonsomatic symptoms of depression in relapsing-remitting multiple sclerosis.
    Sundgren M; Maurex L; Wahlin Å; Piehl F; Brismar T
    Arch Clin Neuropsychol; 2013 Mar; 28(2):144-55. PubMed ID: 23291310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subjective cognitive complaints relate to mild impairment of cognition in multiple sclerosis.
    Marrie RA; Chelune GJ; Miller DM; Cohen JA
    Mult Scler; 2005 Feb; 11(1):69-75. PubMed ID: 15732269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attention impairment associated with relapsing-remitting multiple sclerosis patients with mild incapacity.
    Balsimelli S; Mendes MF; Bertolucci PH; Tilbery CP
    Arq Neuropsiquiatr; 2007 Jun; 65(2A):262-7. PubMed ID: 17607425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disconnection as a mechanism for cognitive dysfunction in multiple sclerosis.
    Dineen RA; Vilisaar J; Hlinka J; Bradshaw CM; Morgan PS; Constantinescu CS; Auer DP
    Brain; 2009 Jan; 132(Pt 1):239-49. PubMed ID: 18953055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different cognitive profiles of Brazilian patients with relapsing-remitting and primary progressive multiple sclerosis.
    Rodrigues DN; Paes RA; Vasconcelos CC; Landeira-Fernandez J; Alvarenga MP
    Arq Neuropsiquiatr; 2011 Aug; 69(4):590-5. PubMed ID: 21877025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using mental visual imagery to improve autobiographical memory and episodic future thinking in relapsing-remitting multiple sclerosis patients: A randomised-controlled trial study.
    Ernst A; Blanc F; De Seze J; Manning L
    Restor Neurol Neurosci; 2015; 33(5):621-38. PubMed ID: 26410206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The subtleties of cognitive decline in multiple sclerosis: an exploratory study using hierarchichal cluster analysis of CANTAB results.
    Cabeça HLS; Rocha LC; Sabbá AF; Tomás AM; Bento-Torres NVO; Anthony DC; Diniz CWP
    BMC Neurol; 2018 Sep; 18(1):140. PubMed ID: 30200902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive phenotypes in multiple sclerosis.
    Leavitt VM; Tosto G; Riley CS
    J Neurol; 2018 Mar; 265(3):562-566. PubMed ID: 29356970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropsychological testing and event-related potentials in the assessment of cognitive performance in the patients with multiple sclerosis--a pilot study.
    Pokryszko-Dragan A; Zagrajek M; Slotwinski K; Gruszka E; Bilinska M; Podemski R
    Clin Neurol Neurosurg; 2009 Jul; 111(6):503-6. PubMed ID: 19233546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive impairment among different clinical courses of multiple sclerosis.
    Brissart H; Morele E; Baumann C; Perf ML; Leininger M; Taillemite L; Dillier C; Pittion S; Spitz E; Debouverie M
    Neurol Res; 2013 Oct; 35(8):867-72. PubMed ID: 23816638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Computerized Test of Information Processing (CTIP) offers an alternative to the PASAT for assessing cognitive processing speed in individuals with multiple sclerosis.
    Tombaugh TN; Berrigan LI; Walker LA; Freedman MS
    Cogn Behav Neurol; 2010 Sep; 23(3):192-8. PubMed ID: 20829669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.